PO178 The Prospective Study of Education as Additive Mortality Risk Indicator In Chronic Coronary Heart Disease Patients

Global Heart ◽  
2018 ◽  
Vol 13 (4) ◽  
pp. 420 ◽  
Author(s):  
O. Mayer ◽  
M. Cvíčela ◽  
J. Bruthans ◽  
J. Gelžinský ◽  
M. Hronová ◽  
...  
2018 ◽  
Vol 47 ◽  
pp. 55-61 ◽  
Author(s):  
Otto Mayer ◽  
Jan Bruthans ◽  
Jitka Seidlerová ◽  
Petra Karnosová ◽  
Jiří Vaněk ◽  
...  

2001 ◽  
Vol 88 (5) ◽  
pp. 516-520 ◽  
Author(s):  
Arthur J. Moss ◽  
Yazid Fadl ◽  
Wojciech Zareba ◽  
David S. Cannom ◽  
W.Jackson Hall

2020 ◽  
Vol 98 (3) ◽  
pp. 231-235
Author(s):  
N. Yu. Borovkova ◽  
M. V. Buyanova ◽  
T. E. Bakka ◽  
M. P. Nistratova ◽  
T. V. Vlasova ◽  
...  

To evaluate possibilities of aspirin-induced gastroduodenopathy treatment in the patients with chronic ischemic heart disease by means of applying the internal endogenous prostaglandins stimulant.  Material and methods. 340 patients suffering from chronic coronary heart disease and receiving a long-term acetylsalicylic acid (ASA) therapy were examined on the base of the cardiovascular care unit of The Nizhny Novgorod Regional Clinical Hospital named after N.A. Semaschko. There were evaluated frequency, nature and severity of the aspirin-induced gastroduodenopathy. The patients with coronary heart disease and aspirin-induced gastroduodenopathy were divided in two groups. In the first group of patients there was applied rebamipide therapy (in a single daily dose 300 mg) in combination with the proton pump inhibitor (PPI) — pantoprazole. In the second group there was applied only pantoprazole therapy. For the purpose of specification of AIG pathogenetic mechanisms development, all the examined chronic coronary heart disease cases were tested on the prostaglandin E2 (PGE2) level in blood serum before the therapy beginning and after the treatment. The control group was formed of chronic coronary heart disease patients showing no AIG evidence. Statistical processing of the received data was fulfilled with the program «Statistika 10.0». Results. AIG was registered in 15% out of 340 chronic coronary heart disease patients. According to the endoscopic examination erosive disease of the body and antrum prevailed among the patients. The PGE2 level in the blood serum was significantly lower (р = 0,00087) in these patients in comparison with the control group. In association with PPI and rebamipide mixed therapy, esophagogastroduodenoscopy results showed no pathological findings in gastrointestinal mucosa and statistically significant (р = 0,00067) blood serum PGE2 level growing in all the treated patients. As a result of exclusive PPI therapy there was marked positive dynamics in endoscopic view in 19 out of 25 patients and a tendency to normalization of PGE2 level in the blood serum. However, PGE2 level growing was insignificant. Conclusion. The presented research demonstrates the possibility of AIG treatment with the use of internal endogenous prostaglandins stimulant — rebamipide in complex with proton pump inhibitor PPI therapy.


Circulation ◽  
1997 ◽  
Vol 96 (4) ◽  
pp. 1102-1108 ◽  
Author(s):  
Aaron R. Folsom ◽  
Kenneth K. Wu ◽  
Wayne D. Rosamond ◽  
A. Richey Sharrett ◽  
Lloyd E. Chambless

1985 ◽  
Vol 110 (4_Suppl) ◽  
pp. S21-S26 ◽  
Author(s):  
R. J. Jarrett ◽  
M. J. Shipley

Summary. In 168 male diabetics aged 40-64 years participating in the Whitehall Study, ten-year age adjusted mortality rates were significantly higher than in non-diabetics for all causes, coronary heart disease, all cardiovascular disease and, in addition, causes other than cardiovascular. Mortality rates were not significantly related to known duration of the diabetes. The predictive effects of several major mortality risk factors were similar in diabetics and non-diabetics. Excess mortality rates in the diabetics could not be attributed to differences in levels of blood pressure or any other of the major risk factors measured. Key words: diabetics; mortality rates; risk factors; coronary heart disease. There are many studies documenting higher mortality rates - particularly from cardiovascular disease -in diabetics compared with age and sex matched diabetics from the same population (see Jarrett et al. (1982) for review). However, there is sparse information relating potential risk factors to subsequent mortality within a diabetic population, information which might help to explain the increased mortality risk and also suggest preventive therapeutic approaches. In the Whitehall Study, a number of established diabetics participated in the screening programme and data on mortality rates up to ten years after screening are available. We present here a comparison of diabetics and non-diabetics in terms of relative mortality rates and the influence of conventional risk factors as well as an analysis of the relationship between duration of diabetes and mortality risk.


Circulation ◽  
1994 ◽  
Vol 89 (5) ◽  
pp. 1992-1997 ◽  
Author(s):  
I Kawachi ◽  
G A Colditz ◽  
A Ascherio ◽  
E B Rimm ◽  
E Giovannucci ◽  
...  

2003 ◽  
Vol XXXV (1-2) ◽  
pp. 78-79
Author(s):  
D. Tanne ◽  
M. Haim ◽  
U. Goldbourt ◽  
V. Boyko ◽  
R. Doolman ◽  
...  

According to modern data, homocysteine damages the vascular endothelium, contributing to the formation of lipid plaques and blood clots. The aim of the study was to determine the risk of ischemic stroke in persons with coronary heart disease, depending on the level of homocysteine in the blood serum.


Sign in / Sign up

Export Citation Format

Share Document